Aslan Pharmaceuticals Price on May 24, 2024
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
If you're considering investing in Aslan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aslan Pharmaceuticals stands at 0.60, as last reported on the 12th of December 2024, with the highest price reaching 0.70 and the lowest price hitting 0.60 during the day. We have found twenty-four technical indicators for Aslan Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Aslan Pharmaceuticals' Risk Adjusted Performance of (0.17), mean deviation of 5.79, and Standard Deviation of 9.4 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Aslan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aslan |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ASLN |
Based on monthly moving average Aslan Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aslan Pharmaceuticals by adding Aslan Pharmaceuticals to a well-diversified portfolio.
Related Headline
Acrivon Therapeutics, Headline on 24th of May 2024
Acquisition by Ra Capital Management, L.p. of 3389500 shares... by Ra Capital Management, L.p.
Filed transaction by Acrivon Therapeutics Common Director, 10 Percent Owner . Grant, award or other acquisition pursuant to Rule 16b-3
Aslan Pharmaceuticals Valuation on May 24, 2024
It is possible to determine the worth of Aslan Pharmaceuticals on a given historical date. On May 24, 2024 Aslan was worth 3.6 at the beginning of the trading date compared to the closed value of 3.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aslan Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Aslan Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aslan Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aslan Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.68 | 3.84 | 3.60 | 3.60 | 19,553 | |
05/24/2024 | 3.60 | 3.76 | 3.60 | 3.75 | 15,420 |
| 3.68 | 3.75 | 3.44 | 3.56 | 13,006 |
| Backtest Aslan Pharmaceuticals | | | Aslan Pharmaceuticals History | | | Aslan Pharmaceuticals Valuation | Previous | Next |
Aslan Pharmaceuticals Trading Date Momentum on May 24, 2024
| On May 28 2024 Aslan Pharmaceuticals was traded for 3.56 at the closing time. The top price for the day was 3.75 and the lowest listed price was 3.44 . The trading volume for the day was 13 K. The trading history from May 28, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.07% . The overall trading delta against the current closing price is 4.27% . |
Aslan Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Aslan Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aslan Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aslan financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aslan Pharmaceuticals Stock history
Aslan Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aslan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aslan Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aslan Pharmaceuticals stock prices may prove useful in developing a viable investing in Aslan Pharmaceuticals
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Aslan Pharmaceuticals Stock Technical Analysis
Aslan Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Aslan Pharmaceuticals Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Aslan Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aslan Pharmaceuticals December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aslan Pharmaceuticals stock market strength indicators, traders can identify Aslan Pharmaceuticals entry and exit signals to maximize returns
Aslan Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aslan Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aslan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aslan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (2.59) | |||
| Total Risk Alpha | (3.81) | |||
| Treynor Ratio | (0.97) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |